fluoxetine has been researched along with aripiprazole in 41 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (21.95) | 29.6817 |
| 2010's | 28 (68.29) | 24.3611 |
| 2020's | 4 (9.76) | 2.80 |
| Authors | Studies |
|---|---|
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Sen, S; Sinha, N | 1 |
| Jung, ME; Kang, SY; Kim, HJ; Kim, J; Kim, MJ; Kim, MS; Lee, J; Lee, KN; Lee, M; Lee, SH; Park, EJ; Park, WK; Seo, HJ; Son, EJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Duggal, HS; Kithas, J | 1 |
| Lunde, H; Lunder, N; Molden, E; Refsum, H | 1 |
| Dobkin, RD; Marin, H; Menza, MA | 1 |
| Arnold, KK; Yager, J | 1 |
| Papakostas, GI; Shelton, RC | 1 |
| Berman, RM; Carson, WH; Fava, M; Hennicken, D; Marcus, RN; McQuade, RD; Simon, JS; Thase, ME; Trivedi, MH | 1 |
| Neill, JC; Snigdha, S | 1 |
| Balch, AH; Berman, RM; Boulton, DW; Mallikaarjun, S; Patel, CG; Reeves, RA; Royzman, K | 1 |
| Kamei, A; Kamei, J; Miyata, S; Ohsawa, M; Shimada, M; Sunohara, T | 1 |
| Apfeldorf, WJ; Cullen, CE; Eide, CE; Lu, BY; Williams, CC | 1 |
| Cruz, N; Goikolea, JM; Sanchez-Moreno, J; Torres, F; Valentí, M; Vieta, E | 1 |
| Brecher, M; Calabrese, JR; Carlson, BX; Edwards, S; Eudicone, JM; Evoniuk, G; Ganocy, SJ; Jansen, W; Kemp, DE; Leon, AC; Minkwitz, M; Pikalov, A; Stassen, HH; Szegedi, A; Tohen, M; Van Willigenburg, AP | 1 |
| Bruzek, JL; Jerome, RN; Krishnaswami, S; McPheeters, ML; Sathe, N; Veenstra-Vanderweele, J; Warren, Z | 1 |
| Chiang, KT; Huang, LC | 1 |
| Babu, GN; Chandra, P; Kumar, R; Saddichha, S | 1 |
| Cavanna, AE; Rickards, H; Worrall, R | 1 |
| Ahlbrand, R; Bronson, SL; Grainger, M; Horn, P; McNamara, RK; Richtand, NM; Tambyraja, R | 1 |
| Rittmannsberger, H; Werl, R | 1 |
| Baker, RA; Forbes, RA; Jing, Y; Oster, G; Papakostas, GI; Taneja, C | 1 |
| Lin, CC; Lin, HY; Liu, CC | 1 |
| Burda-Malarz, K; Czubak, A; Hardyk, S; Kus, K; Nowakowska, E; Ratajczak, P | 1 |
| Burda-Malarz, K; Czubak, A; Jędrzejewski, L; Kus, K; Nowakowska, E; Ratajczak, P; Sadowski, C | 1 |
| Philip, NS | 1 |
| Cornelius, V; Smith, L; Taylor, DM; Young, AH | 1 |
| Alparslan, S; Eryilmaz, G; Isiten, N; Mutlu, C; Ozilhan, S; Saglam, E; Yorbik, O | 1 |
| Abrial, E; Bétourné, A; Etiévant, A; Haddjeri, N; Lambás-Señas, L; Lucas, G; Scarna, H | 1 |
| Chang, CH; Chang, YC; Chen, YW; Cheng, YS; Chung, W; Tseng, PT; Wang, HY; Wu, CK | 1 |
| Sewell, DD; Vahia, IV | 1 |
| Das, A; Jha, S; Kumar, P; Kumar, R | 1 |
| Czaja, N; Kus, K; Nowakowska, E; Ratajczak, P; Zaprutko, T | 1 |
| Boustany, RM; Khalifeh, S; Kourtian, S; Yassin, W | 1 |
| Hirakawa, M; Kunisawa, K; Libo, Z; Lu, Q; Mori, Y; Mouri, A; Nabeshima, T; Saito, K; Teshigawara, T; Yamamoto, Y; Yang, Y | 1 |
| Cheng, X; Dong, W; Feng, W; Li, H; Wang, M; Zhang, D | 1 |
| Bodoukhin, N; Botros, M; Luca, L; Taylor, R | 1 |
| Jauhar, S; Kaufman, KR; Kerr-Gaffney, J; Kurana, S; Strawbridge, R; Yalin, N; Young, AH | 1 |
| Alexinschi, O; Carvalho, AF; Cavaliere, L; Correll, CU; Cortese, S; Croatto, G; Fiedorowicz, JG; Firth, J; Fusar-Poli, P; Gaina, MA; Makkai, V; Miola, A; Olivola, M; Shin, JI; Soares, FC; Solmi, M; Stubbs, B; Vancampfort, D; Vianello, G; Vieta, E | 1 |
9 review(s) available for fluoxetine and aripiprazole
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Augmentation of antidepressants with atypical antipsychotics for treatment-resistant major depressive disorder.
Topics: Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Depressive Disorder, Major; Dibenzothiazepines; Dopamine D2 Receptor Antagonists; Drug Resistance; Drug Therapy, Combination; Fluoxetine; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Serotonin 5-HT2 Receptor Antagonists; Thiazoles; Trazodone; Triazoles | 2008 |
Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis.
Topics: Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Drug Combinations; Drug Therapy, Combination; Fluoxetine; Humans; Olanzapine; Piperazines; Placebos; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Treatment Outcome | 2010 |
A systematic review of medical treatments for children with autism spectrum disorders.
Topics: Antipsychotic Agents; Aripiprazole; Child; Child Development Disorders, Pervasive; Child, Preschool; Citalopram; Dose-Response Relationship, Drug; Drug Administration Schedule; Evidence-Based Medicine; Female; Fluoxetine; Humans; Male; Patient Compliance; Piperazines; Prognosis; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Serotonin Antagonists; Severity of Illness Index; Treatment Outcome | 2011 |
Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple-treatments meta-analysis.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Depression; Dibenzothiazepines; Drug Therapy, Combination; Fluoxetine; Humans; Isoindoles; Lamotrigine; Lithium Compounds; Lurasidone Hydrochloride; Monoamine Oxidase Inhibitors; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Selective Serotonin Reuptake Inhibitors; Thiazoles; Treatment Outcome; Triazines; Valproic Acid | 2014 |
Atypical neuroleptic malignant syndrome in patients treated with aripiprazole and clozapine: a case-series study and short review.
Topics: Adult; Aripiprazole; Clozapine; Creatine Kinase; Dose-Response Relationship, Drug; Drug Substitution; Drug Therapy, Combination; Female; Fluoxetine; Hospitalization; Humans; Injections, Intramuscular; Male; Middle Aged; Neuroleptic Malignant Syndrome; Piperazines; Psychotic Disorders; Quinolones; Schizophrenia; Schizophrenic Psychology | 2015 |
AUTISM IN REVIEW.
Topics: Aripiprazole; Autism Spectrum Disorder; Central Nervous System Agents; Diagnostic and Statistical Manual of Mental Disorders; Diffusion Tensor Imaging; Fluoxetine; Humans; Risk Factors; Risperidone; White Matter | 2016 |
A systematic review and meta-analysis of treatments for rapid cycling bipolar disorder.
Topics: Aripiprazole; Bipolar Disorder; Citalopram; Fluoxetine; Humans; Lamotrigine; Olanzapine; Quetiapine Fumarate; Venlafaxine Hydrochloride | 2022 |
The impact of pharmacological and non-pharmacological interventions on physical health outcomes in people with mood disorders across the lifespan: An umbrella review of the evidence from randomised controlled trials.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Fluoxetine; Glycated Hemoglobin; Humans; Longevity; Olanzapine; Outcome Assessment, Health Care; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors | 2023 |
4 trial(s) available for fluoxetine and aripiprazole
| Article | Year |
|---|---|
An open-label trial of aripiprazole augmentation for treatment-resistant generalized anxiety disorder.
Topics: Adolescent; Adult; Aged; Akathisia, Drug-Induced; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Bupropion; Dizziness; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluoxetine; Headache; Humans; Male; Middle Aged; Nausea; Paroxetine; Pilot Projects; Piperazines; Quality of Life; Quinolones; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2007 |
The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.
Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents; Aripiprazole; Citalopram; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Fatigue; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Quinolones; Sertraline; Single-Blind Method; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride; Weight Gain; Withholding Treatment | 2008 |
The pharmacokinetics of standard antidepressants with aripiprazole as adjunctive therapy: studies in healthy subjects and in patients with major depressive disorder.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Citalopram; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Drug Interactions; Female; Fluoxetine; Humans; Male; Middle Aged; Piperazines; Quinolones; Sertraline; Treatment Outcome; United States; Venlafaxine Hydrochloride; Young Adult | 2010 |
Clinical value of early partial symptomatic improvement in the prediction of response and remission during short-term treatment trials in 3369 subjects with bipolar I or II depression.
Topics: Antidepressive Agents, Second-Generation; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Drug Therapy, Combination; Fluoxetine; Humans; Lamotrigine; Olanzapine; Piperazines; Predictive Value of Tests; Psychiatric Status Rating Scales; Quetiapine Fumarate; Quinolones; Remission Induction; Sensitivity and Specificity; Time Factors; Treatment Outcome; Triazines | 2011 |
28 other study(ies) available for fluoxetine and aripiprazole
| Article | Year |
|---|---|
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
Design and synthesis of novel arylpiperazine derivatives containing the imidazole core targeting 5-HT(2A) receptor and 5-HT transporter.
Topics: Animals; Antidepressive Agents; Binding, Competitive; CHO Cells; Cricetinae; Cricetulus; Drug Design; Humans; Imidazoles; Male; Mice; Motor Activity; Piperazines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Antagonists; Serotonin Plasma Membrane Transport Proteins; Stereoisomerism; Structure-Activity Relationship | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Possible neuroleptic malignant syndrome with aripiprazole and fluoxetine.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Depressive Disorder; Drug Therapy, Combination; Fluoxetine; Humans; Male; Neuroleptic Malignant Syndrome; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors | 2005 |
Pharmacokinetic variability of aripiprazole and the active metabolite dehydroaripiprazole in psychiatric patients.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Cytochrome P-450 CYP2D6 Inhibitors; Drug Monitoring; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Piperazines; Quinolones | 2006 |
A case of unexpected and selective remission of a 20-year history of ephedrine dependence following treatment with low-dose aripiprazole.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Depressive Disorder, Major; Drug Administration Schedule; Drug Therapy, Combination; Ephedrine; Feeding and Eating Disorders; Female; Fluoxetine; Humans; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors; Substance-Related Disorders | 2007 |
Improvement of phencyclidine-induced social behaviour deficits in rats: involvement of 5-HT1A receptors.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Aripiprazole; Behavior, Animal; Chlordiazepoxide; Female; Fluoxetine; GABA Modulators; Phencyclidine; Piperazines; Pyridines; Quinolones; Rats; Receptor, Serotonin, 5-HT1A; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Social Behavior Disorders | 2008 |
Potentiation of the antidepressant-like effect of fluoxetine by aripiprazole in the mouse tail suspension test.
Topics: Animals; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Aripiprazole; Behavior, Animal; Blood Glucose; Dose-Response Relationship, Drug; Drug Synergism; Fluoxetine; Hindlimb Suspension; Male; Mice; Mice, Inbred ICR; Models, Animal; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors; Time Factors | 2008 |
Antidepressant-induced sweating alleviated by aripiprazole.
Topics: Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Dopamine Agonists; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Hyperhidrosis; Middle Aged; Piperazines; Quinolones; Sweating; Thiophenes | 2008 |
Aripiprazole-associated leukopenia with coadministration of fluoxetine: a case report.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Drug Therapy, Combination; Fluoxetine; Humans; Leukopenia; Male; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors | 2011 |
Aripiprazole associated with acute dystonia, akathisia, and parkinsonism in a single patient.
Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Aripiprazole; Depression; Dystonia; Female; Fluoxetine; Humans; Parkinsonian Disorders; Piperazines; Psychotic Disorders; Quinolones | 2012 |
Treatment practices in Tourette syndrome: the European perspective.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Anxiety; Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clonidine; Depression; Europe; Fluoxetine; Fluvoxamine; Health Care Surveys; Humans; Methylphenidate; Obsessive-Compulsive Disorder; Physicians; Piperazines; Propylamines; Psychiatry; Quinolones; Risperidone; Sertraline; Sulpiride; Tourette Syndrome | 2012 |
Fluoxetine and aripiprazole treatment following prenatal immune activation exert longstanding effects on rat locomotor response.
Topics: Acute-Phase Reaction; Amphetamine; Animals; Antipsychotic Agents; Aripiprazole; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Fluoxetine; Immune System; Male; Motor Activity; Piperazines; Poly I-C; Pregnancy; Prenatal Exposure Delayed Effects; Quinolones; Rats; Rats, Sprague-Dawley; Schizophrenia; Selective Serotonin Reuptake Inhibitors | 2012 |
Does aripiprazole protect from serotonin syndrome?
Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Aripiprazole; Borderline Personality Disorder; Cyclohexanols; Cytochrome P-450 CYP2D6 Inhibitors; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetine; Humans; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Tremor; Venlafaxine Hydrochloride; Young Adult | 2012 |
Cost-effectiveness of adjunctive therapy with atypical antipsychotics for acute treatment of major depressive disorder.
Topics: Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Cost-Benefit Analysis; Decision Support Techniques; Depressive Disorder, Major; Dibenzothiazepines; Drug Combinations; Drug Costs; Drug Resistance; Fluoxetine; Health Care Costs; Humans; Piperazines; Quetiapine Fumarate; Quinolones | 2012 |
Hypomania associated with adjunctive aripiprazole in an elder female with recurrent major depressive disorder: dose-related phenomenon?
Topics: Aripiprazole; Bipolar Disorder; Clonazepam; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluoxetine; Humans; Middle Aged; Piperazines; Quinolones; Recurrence | 2012 |
Evaluation of the antidepressant, anxiolytic and memory-improving efficacy of aripiprazole and fluoxetine in ethanol-treated rats.
Topics: Alcoholism; Animals; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Behavior, Animal; Drug Therapy, Combination; Ethanol; Fluoxetine; Male; Maze Learning; Piperazines; Quinolones; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Spatial Memory; Swimming | 2014 |
Evaluation of antidepressant and memory-improving efficacy of aripiprazole and fluoxetine in alcohol-preferring rats.
Topics: Alcoholism; Animals; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Fluoxetine; Male; Piperazines; Quinolones; Rats; Rats, Wistar; Spatial Memory | 2014 |
An aripiprazole discontinuation syndrome.
Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Depressive Disorder, Major; Drug Therapy, Combination; Female; Fluoxetine; Humans; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome | 2013 |
Plasma Methylphenidate Levels in Youths With Attention Deficit Hyperactivity Disorder Treated With OROS Formulation.
Topics: Administration, Oral; Adolescent; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Interactions; Female; Fluoxetine; Humans; Male; Methylphenidate; Retrospective Studies; Risperidone; Sertraline | 2015 |
Protein kinase C inhibition rescues manic-like behaviors and hippocampal cell proliferation deficits in the sleep deprivation model of mania.
Topics: Animals; Antidepressive Agents, Second-Generation; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzophenanthridines; Bipolar Disorder; Cell Proliferation; Disease Models, Animal; Fluoxetine; Hippocampus; Lithium Chloride; Male; Piperazines; Prefrontal Cortex; Protein Kinase C; Protein Kinase Inhibitors; Quinolones; Rats, Sprague-Dawley; Sleep Deprivation; Tamoxifen | 2014 |
Late-Life Depression: A Role for Accelerometer Technology in Diagnosis and Management.
Topics: Actigraphy; Aged, 80 and over; Antidepressive Agents; Aripiprazole; Depression; Exercise; Fluoxetine; Humans; Male; Sleep Wake Disorders | 2016 |
Effectiveness of add-on l-methylfolate therapy in a complex psychiatric illness with MTHFR C677 T genetic polymorphism.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Depressive Disorder, Treatment-Resistant; Drug Therapy, Combination; Fluoxetine; Humans; Lithium Compounds; Male; Methylenetetrahydrofolate Reductase (NADPH2); Obsessive-Compulsive Disorder; Polymorphism, Genetic; Tetrahydrofolates; Vitamin B Complex | 2016 |
Effect of combined administration of aripiprazole and fluoxetine on cognitive functions in female rats exposed to ethyl alcohol.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Avoidance Learning; Central Nervous System Depressants; Cognition Disorders; Disease Models, Animal; Drug Therapy, Combination; Ethanol; Female; Fluoxetine; Locomotion; Maze Learning; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Reaction Time; Time Factors | 2017 |
Chronic unpredictable mild stress-induced behavioral changes are coupled with dopaminergic hyperfunction and serotonergic hypofunction in mouse models of depression.
Topics: Animals; Aripiprazole; Behavior, Animal; Depression; Depressive Disorder, Major; Disease Models, Animal; Dopamine; Fluoxetine; Hippocampus; Male; Mice; Mice, Inbred C57BL; Nucleus Accumbens; Prefrontal Cortex; Serotonin; Signal Transduction; Stress, Psychological; Tryptophan Hydroxylase; Tyrosine 3-Monooxygenase | 2019 |
A UPLC-MS/MS Assay for Simultaneous Determination of Two Antipsychotics and Two Antidepressants in Human Plasma and Its Application in Clinic.
Topics: Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Chromatography, High Pressure Liquid; Citalopram; Drug Monitoring; Fluoxetine; Humans; Risperidone; Tandem Mass Spectrometry | 2020 |
Joy Journal: A Behavioral Activation Technique Used in the Treatment of Late-Life Depression Associated With Hopelessness During the COVID-19 Pandemic.
Topics: Aged; Antidepressive Agents; Aripiprazole; Cognitive Behavioral Therapy; COVID-19; Depressive Disorder, Major; Female; Fluoxetine; Happiness; Hope; Hospitalization; Humans; SARS-CoV-2; Suicidal Ideation; Unemployment | 2021 |